Related Experiment Video
Updated: May 9, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus
Ryan S Noyce1, Daniel G Bondre, Michael N Ha
1Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract:
Vaccine and laboratory adapted strains of measles virus can use CD46 as a receptor to infect many human cell lines. However, wild type isolates of measles virus cannot use CD46, and they infect activated lymphocytes, dendritic cells, and macrophages via the receptor CD150/SLAM. Wild type virus can also infect epithelial cells of the respiratory tract through an unidentified receptor. We demonstrate that wild type measles virus infects primary airway epithelial cells grown in fetal calf serum and many adenocarcinoma cell lines of the lung, breast, and colon. Transfection of non-infectable adenocarcinoma cell lines with an expression vector encoding CD150/SLAM rendered them susceptible to measles virus, indicating that they were virus replication competent, but lacked a receptor for virus attachment and entry. Microarray analysis of susceptible versus non-susceptible cell lines was performed, and comparison of membrane protein gene transcripts produced a list of 11 candidate receptors. Of these, only the human tumor cell marker PVRL4 (Nectin 4) rendered cells amenable to measles virus infections. Flow cytometry confirmed that PVRL4 is highly expressed on the surfaces of susceptible lung, breast, and colon adenocarcinoma cell lines. Measles virus preferentially infected adenocarcinoma cell lines from the apical surface, although basolateral infection was observed with reduced kinetics. Confocal immune fluorescence microscopy and surface biotinylation experiments revealed that PVRL4 was expressed on both the apical and basolateral surfaces of these cell lines. Antibodies and siRNA directed against PVRL4 were able to block measles virus infections in MCF7 and NCI-H358 cancer cells. A virus binding assay indicated that PVRL4 was a bona fide receptor that supported virus attachment to the host cell. Several strains of measles virus were also shown to use PVRL4 as a receptor. Measles virus infection reduced PVRL4 surface expression in MCF7 cells, a property that is characteristic of receptor-associated viral infections.
Insights
Wild type measles virus infects cancer cells using PVRL4 (Nectin 4) as a receptor. This discovery identifies a new target for understanding measles virus tropism and developing antiviral therapies.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Vaccine strains of measles virus utilize CD46 for cell entry.
- Wild-type measles virus infects immune cells via CD150/SLAM and respiratory epithelial cells via an unknown receptor.
Purpose of the Study:
- To identify the receptor used by wild-type measles virus to infect epithelial cells, particularly adenocarcinoma cell lines.
- To investigate the role of potential receptors in measles virus tropism and infection mechanisms.
Main Methods:
- Transfection of cell lines to assess susceptibility.
- Microarray analysis to identify candidate receptors.
- Flow cytometry, immune fluorescence microscopy, and surface biotinylation to characterize receptor expression and localization.
- Virus binding assays and blocking experiments using antibodies and siRNA.
Main Results:
- Wild-type measles virus infects lung, breast, and colon adenocarcinoma cell lines.
- PVRL4 (Nectin 4) was identified as a functional receptor for wild-type measles virus entry.
- PVRL4 is expressed on both apical and basolateral surfaces of susceptible cells.
- Antibodies and siRNA targeting PVRL4 blocked measles virus infection.
Conclusions:
- PVRL4 (Nectin 4) is a bona fide receptor for wild-type measles virus, mediating its attachment and entry into adenocarcinoma cells.
- Identification of PVRL4 provides insights into measles virus tropism and potential therapeutic strategies.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Tumor Immunotherapy

